No insider purchase over the last 90 days. The latest, by Rosenbloom Ronen, was filed 26 Dec 2024.
Nexentis Technologies Inc., classified in the Chemicals sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). In the past year (23 October 2025 to 23 October 2026), 14 filings came from 10 insiders.
The flow runs one way only: 1 sale worth €144, from 1 insider, and no purchase. Biggest ticket of the year: €144, sold by Lee Eun Young and made public on 26 March 2026.
Compared with its exchange (3,166 companies, median 24 filings), a count of 14 filings is below the norm. Our records for Nexentis Technologies Inc. go back to 2020, with 8 purchases and 1 sale on the open market in total.
Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
For comparison within the same sector, see the insider buying recorded at Heidelberg Materials AG and Titan. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2025 · cache
25 of 38 declarations
Nexentis Technologies Inc. is a company listed on the XNAS market, specializing in the development of innovative technology solutions. It focuses on enhancing the efficiency of energy systems.
Purchases our model currently ranks for the recommendations list.
All recommendationsInsider filings
Over the last 90 days, 9 filings published between 19 October and 22 October 2026: no open-market purchase or sale filed by an insider. 9 other filings (not open-market purchases or sales: grants, options, plans, sale notices, block transfers).
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 23 October 2026 (UTC)
| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2024 | 210,000 USD | -5.2 m USD | -27.74 USD | 10-K |
| Dec 2023 | 263,445 USD | -6.5 m USD | -5.43 USD | 10-K |
| Dec 2022 | 394,004 USD | -5.7 m USD | 10.85 USD | 10-K |
| Dec 2021 | 438,141 USD | -4.8 m USD | n.d. | 10-K |
| Dec 2020 | 232,274 USD | -1.6 m USD | n.d. | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.